Inventor · disambiguated record
Mohammad R. Marzabadi
Also filed as: MARZABADI MOHAMMAD · MARZABADI MOHAMMAD R
26 granted patents·12 pending applications·602 citations·filing 1995–2020
97Inventor score
Files withSYNAPTIC PHARMA CORP20LUNDBECK & CO AS H10MARZABADI MOHAMMAD R4LUNBECK AS H1LUNDBICK AS H1
Top patents by PatentIndex Score
38 records- 0195US6727264B1Substituted anilinic piperidines as MCH selective antagonistsSYNAPTIC PHARMA CORP·Filed 2002·Granted Apr 27, 2004·61 cites·20 claims
- 0295US6620815B1Oxazolidinones and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted Sep 16, 2003·50 cites·40 claims
- 0395US6340683B1Selective NPY (Y5) antagonists (triazines)SYNAPTIC PHARMA CORP·Filed 1999·Granted Jan 22, 2002·97 cites·29 claims
- 0494US6720324B2Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Granted Apr 13, 2004·51 cites·18 claims
- 0593US7273880B2Selective NPY (Y5) antagonistsNOVARTIS AG·Filed 2005·Granted Sep 25, 2007·20 cites·1 claims
- 0687US6218408B1Selective NPY (Y5) antagonists (bicyclics)SYNAPTIC PHARMA CORP·Filed 1999·Granted Apr 17, 2001·43 cites·26 claims
- 0786US6245773B15-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 1997·Granted Jun 12, 2001·34 cites·19 claims
- 0885US6159990AOxazolidinones as α1A receptor antagonistsSYNAPTIC PHARMA CORP·Filed 1998·Granted Dec 12, 2000·66 cites·38 claims
- 0982US6124331ASelective NPY (Y5) antagonists (tricyclics)SYNAPTIC PHARMA CORP·Filed 1999·Granted Sep 26, 2000·31 cites·21 claims
- 1080US6569856B2Selective NPY (Y5) antagonists (triazines)SYNAPTIC PHARMA CORP·Filed 2002·Granted May 27, 2003·10 cites·27 claims
- 1178US7067534B1Substituted anilinic piperidines as MCH selective antagonistsLUNDBECK & CO AS H·Filed 2003·Granted Jun 27, 2006·7 cites·12 claims
- 1277US6225330B1Selective NPY (Y5) antagonists (tricyclics)SYNAPTIC PHARMA CORP·Filed 1999·Granted May 1, 2001·22 cites·23 claims
- 1376US6214853B1Selective NPY (Y5) antagonists (bicyclics)SYNAPTIC PHARMA CORP·Filed 1999·Granted Apr 10, 2001·23 cites·16 claims
- 1474US6727257B15-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 2000·Granted Apr 27, 2004·7 cites·42 claims
- 1572US5942517A5-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 1997·Granted Aug 24, 1999·28 cites·29 claims
- 1670US6268369B15-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 1995·Granted Jul 31, 2001·28 cites·21 claims
- 1767US7335665B2Spirocyclic piperidines as MCH1 antagonists and uses thereofLUNDBECK & CO AS H·Filed 2003·Granted Feb 26, 2008·4 cites·41 claims
- 1860US2008139555A1Arylthiobenzylpiperidine DerivativesLUNDBECK & CO AS H·Filed 2008·Application pending·0 cites
- 1959US7473698B2Secondary amino anilinic piperidines as MCH1 antagonists and uses thereofLUNBECK AS H·Filed 2003·Granted Jan 6, 2009·3 cites·21 claims
- 2059US6989379B1Selective NPY (Y5) antagonistsLUNDBICK AS H·Filed 2000·Granted Jan 24, 2006·4 cites·29 claims
- 2159US6222040B1Selective NPY (Y5) antagonists (tricyclics)SYNAPTIC PHARMA CORP·Filed 1999·Granted Apr 24, 2001·8 cites·21 claims
- 2257US7199135B2Substituted alkyl amido piperidinesLUNDBECK & CO AS H·Filed 2004·Granted Apr 3, 2007·1 cites·36 claims
- 2356US2007043080A1Substituted anilinic piperidines as MCH selective antagonistsMARZABADI MOHAMMAD R·Filed 2005·Application pending·0 cites
- 2453US2008045524A1Selective NPY (Y5) antagonistsLUNDBECK & CO AS H·Filed 2007·Application pending·0 cites
- 2551US7329656B2Arylthiobenzylpiperidine derivativesLUNDBECK & CO AS H·Filed 2005·Granted Feb 12, 2008·0 cites·21 claims
- 2650US2006217418A1Substituted alkyl amido piperidinesMARZABADI MOHAMMAD R·Filed 2004·Application pending·0 cites
- 2749US7189720B2Selective NPY (Y5) antagonistsLUNDBECK & CO AS H·Filed 2005·Granted Mar 13, 2007·0 cites·16 claims
- 2849US7105544B2Substituted alkyl amido piperidinesLUNDBECK & CO AS H·Filed 2003·Granted Sep 12, 2006·0 cites·27 claims
- 2949US2022257601A1Inhibitors of prc1 for treatment of cancerUNIV TEXAS·Filed 2020·Application pending·0 cites
- 3049US2004242609A1Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereofSYNAPTIC PHARMA CORP·Filed 2004·Application pending·0 cites
- 3148US7446204B2Amino substituted aryloxybenzylpiperidine derivativesLUNDBECK & CO AS H·Filed 2005·Granted Nov 4, 2008·0 cites·7 claims
- 3248US2004019050A1Selective NPY (Y5) antagonists (triazines)SYNAPTIC PHARMA CORP·Filed 2003·Application pending·0 cites
- 3346US2006079683A1Arylthiobenzylpiperidine derivativesMARZABADI MOHAMMAD R·Filed 2004·Application pending·0 cites
- 3446US2006079522A1Amino substituted aryloxybenzylpiperidine derivativesMARZABADI MOHAMMAD R·Filed 2004·Application pending·0 cites
- 3545US2002010186A1Dihydropyrimidines and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Application pending·0 cites
- 3644US2005154020A14-Aryl piperidinesSYNAPTIC PHARMA CORP·Filed 2004·Application pending·0 cites
- 3743US6248747B15-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 1999·Granted Jun 19, 2001·4 cites·11 claims
- 3843US2005154022A14-aryl piperidinesLUNDBECK & CO AS H·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mohammad R. Marzabadi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →